Valuation Mangalam Drugs & Organics Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. 07:05:09 2026-10-15 EDT			5-day change	1st Jan Change
31.62 ^INR	-2.53%		+0.44%	+14.94%

08-17	Mangalam Drugs and Organics Limited Discloses Default on Bank Loan Accounts with Bank of Baroda and Bank of Maharashtra	CI
08-12	Mangalam Drugs & Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	1,573	1,628	1,549	1,466	1,175	439.1
Change	-	3.47%	-4.86%	-5.31%	-19.89%	-62.62%
Enterprise Value (EV) ¹	2,264	2,487	2,407	2,525	2,111	1,560
Change	-	9.85%	-3.22%	4.87%	-16.37%	-26.13%
P/E	5.63x	8.28x	122x	-16.2x	17.5x	-0.99x
PBR	1.2x	1.08x	1.02x	1.08x	0.79x	0.43x
PEG	-	-0.3x	-1.3x	0x	-0x	0x
Capitalization / Revenue	0.41x	0.36x	0.42x	0.4x	0.37x	0.19x
EV / Revenue	0.6x	0.56x	0.65x	0.69x	0.66x	0.67x
EV / EBITDA	4.34x	5.65x	9.99x	32.9x	6.39x	-8.93x
EV / EBIT	5.08x	7.01x	16.5x	90.2x	10.8x	-4.8x
EV / FCF	-8.49x	-10.4x	-54.9x	-37.3x	18.2x	30.9x
FCF Yield	-11.8%	-9.58%	-1.82%	-2.68%	5.51%	3.23%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	17.67	12.42	0.8	-5.731	4.246	-28.05
Distribution rate	-	-	-	-	-	-
Net sales ¹	3,801	4,476	3,702	3,674	3,176	2,321
EBITDA ¹	521.9	440.6	241.1	76.84	330.2	-174.6
EBIT ¹	445.5	355	146.3	27.98	195.6	-324.6
Net income ¹	279.7	196.6	12.7	-90.72	67.21	-444
Net Debt ¹	691.1	859.5	858.6	1,058	936.4	1,121
Reference price ²	99.40	102.85	97.85	92.65	74.22	27.74
Nbr of stocks (in thousands)	15,828	15,828	15,828	15,828	15,828	15,828
Announcement Date	9/2/21	9/2/22	9/6/23	9/4/24	9/7/25	8/31/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	34.58x	12.46x	26.12x	0.57%	1,077B
JOHNSON & JOHNSON	37.53x	6.26x	17.55x	2.1%	612B
ABBVIE INC.	36.12x	8.31x	17.13x	2.45%	501B
MERCK & CO., INC.	113.84x	6x	25.7x	2.32%	364B
ROCHE HOLDING AG	20.01x	4.88x	12.13x	2.7%	353B
NOVARTIS AG	20.46x	5.37x	13.21x	2.96%	278B
ASTRAZENECA PLC	21.15x	4.27x	12.26x	2.07%	251B
AMGEN INC.	27.06x	6.97x	12.48x	2.37%	230B
GILEAD SCIENCES, INC.	-44.86x	6.85x	26.64x	2.14%	190B
Average	29.54x	6.82x	18.14x	2.19%	428.5B
Weighted average by Cap.	35.12x	7.99x	19.65x	1.87%